Platelet Rich Plasma Market

Introduction

Platelet-rich plasma market remains influenced by its integral use in the healthcare industry, especially in orthopedic surgeries and cosmetic surgeries. Injuries like rotator cuff, tendon injuries, tennis elbow and hamstring among others are healed quickly and effectively with the help of platelet-rich plasma therapy.

Besides, a number of sports injuries are also healed by using platelet-rich plasma therapy. Treatment of medical conditions such as erectile dysfunction and facelift surgeries are some of new application areas in the platelet-rich plasma market.

Platelet-rich plasma is a product derived from blood plasma, consisting of enriched platelets, along with several other growth factors, that assist the quick healing of bone and other soft tissues.

Due to the several application areas where platelet-rich plasma therapy can be used, especially in cosmetic surgeries, growth of the platelet-rich plasma market has remained significant. However, the high cost of the medical devices associated with platelet-rich plasma therapy may act as a restraint to the growth of the platelet rich plasma market.

Platelet-rich plasma is a type of blood plasma product in which the concentration of platelets is much higher, more than four to eight times higher than the normal concentration of blood platelets.

Platelet-rich plasma is also known as platelet enriched plasma, platelet-rich gel and platelet enriched gels. It is used in the quick and effective treatment of many medical conditions such as orthopedic diseases, neurological diseases, sports injuries and cardiothoracic diseases. Additionally, platelet-rich plasma has vast applications in the field of cosmetic surgery.

This Fact.MR report on the global platelet-rich plasma market forecasts that the global platelet-rich plasma market will touch a value of nearly US$ 391 Mn in the year 2022 and grow at a robust CAGR during the assessment period, 2017-2022.

North America Set to Dominate Global Platelet-rich Plasma Market

North America is set to lead the global platelet-rich plasma market in terms of value and this trend is projected to sustain itself throughout the assessment period.

North America’s platelet-rich plasma market is expected to remain the most attractive, growing at a robust CAGR through 2022.

PRP Therapy Instruments Poised to Touch Nearly US$ 86 Mn Value by 2022-end

As per the forecast of Fact.MR, the instruments segment is expected to reach a value of nearly US$ 86 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022.

Instruments segment is expected to account for more than one-fourth of the revenue share of the global platelet-rich plasma market by the year 2017, but, is also expected to lose market share by the end of the year 2022.

Hospitals – Key End-users of Platelet-rich Plasma

As per the forecast of Fact.MR, the hospitals end user segment is slated to touch a figure of nearly US$ 184 Mn in the year 2022. This represents a CAGR of 10.0% during the assessment period from 2017 till the year 2022.

This segment is expected to lose market share by the end of the year 2022. The hospitals end user segment accounted for nearly half of the revenue share of the platelet-rich plasma market in 2017.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global platelet-rich plasma market through 2022, which include

• Arthrex, Inc.
• Johnson & Johnson
• Zimmer Biomet Holdings, Inc.
• Exactech, Inc.
• Stryker Corporation
• Terumo Medical Corporation
• Biotest Aktiengesellschaft and CSL Limited.

Market Taxonomy

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Platelet-rich plasma market is growing at a steady pace due to the vast application areas in which it is used in the healthcare industry.

The areas of application of platelet-rich plasma therapy include orthopedic diseases, neurological diseases, sports injuries and cosmetic surgery. This Fact.MR report analyzes the expansion of global platelet rich plasma market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.

Scope

The scope of Fact.MR’s report is to analyze the global platelet-rich plasma market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis.

Platelet-rich plasma therapy providers, research institutes, and key players in the global platelet-rich plasma market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to platelet-rich plasma therapy.

Summary

The report commences with a brief information of the global platelet-rich plasma market. This executive summary sets the tone for the rest of the report, providing users the scope of the report.

The executive summary includes important facts and statistics on the global platelet-rich plasma market.

Overview

The next section offers an overview of the global platelet-rich plasma market. This comprises an introduction to the market, along with a standard definition of the service – platelet-rich plasma therapy.

In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.

The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.

In order to offer readers with up-to-date information about the latest advancements in the global platelet-rich plasma market, the report provides updates about market opportunities, which can benefit leading service providers of platelet-rich plasma therapy.

With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for key market players to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of key players, and cost structure are provided in this section.

The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global platelet-rich plasma market. Product type, end user, application and region are key segments that define the growth of the global market for platelet-rich plasma.

In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.

The report’s last section comprises of the global platelet-rich plasma market competitive landscape, to provide readers with the dashboard view of company analysis and market players.

This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global platelet-rich plasma market.

Research Methodology

Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research.

We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,

• Primary research
• Secondary research
• Trade research
• Focused interviews
• Social media analysis